Teva Hires Kare Schultz as CEO: Is a Recovery in the Cards?

Teva Pharmaceutical Industries Limited announced the appointment of Kåre Schultz as president and chief executive officer, thus ending the Israeli generic maker’s long search for a permanent CEO. Share rose more than 12% in pre-market trading.